Gene Query: BICD2

Dataset Description Geneva Score
Gene expression changes after LOC550643 silencing 65.7
miR941 overexpression experiment 57.55
Identification of Nrf2 regulated genes by RNA sequencing 49.27
Nrf2 regulated genes in A549 cells 49.27
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 42.39
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 42.39
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 36.8
Paxillin regulates genomic networks in prostate cancer [C4-2] 34.42
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 34.37
The cohesin complex prevents Myc-induced replication stress 33.1
Role for citron kinase in prostate cancer growth 32.42
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 29.54
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 27.26
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 26.58
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 24.93
Region-specific Innate Antiviral Responses of the Human Epididymis 24.88
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 24.35
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 22.75
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 22.71
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 22.04
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 20.53
Uridylation by TUT4 and TUT7 marks mRNA for degradation 20.21
Characterization of the Merkel cell carcinoma miRNome 19.68
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 19.0
HNF1 regulates critical functions of the human epididymis epithelium. 19.0
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 18.87
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 18.87
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 18.52
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 18.37
CD73 knockdown effect in pancreatic cancer cell lines 18.36
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 18.05
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 17.72
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 17.12
Intron retention induced by microsatellite expansions as a disease biomarker. 16.75
EGR1-controlled transcriptome of T HESCs 16.75
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 16.42
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 16.24
Genome wide expression change by RNF168 knocking down in NEC cells 16.17
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 16.06
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 15.9
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 15.89
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 15.43
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 15.31
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 15.31
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 15.0
Primary Human B-cell Temporal Response to CD40L Stimulation 14.69
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 14.67
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 14.5
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 14.42
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 14.42
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 14.38
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 14.2
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 13.38
Effect of FGF13 depletion on the H460 cell line 13.33
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 13.29
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 13.21
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 13.21
Gene expression analysis of dengue-infected cells 13.16
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 12.71
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 12.63
Tpl-2 and MEK small molecule inhibitors 12.62
Tpl-2 small molecule project 12.62
Genome wide miR-191 target profile determined by RIP and gene expression profiling 12.57
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 12.57
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 12.53
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 12.53
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 12.2
Transcriptomic and gene ontology profiling of the human corneal cell types 12.16
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 12.14
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 12.03
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 11.95
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 11.59
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 11.59
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 11.56
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 11.49
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 11.42
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 11.41
MYC dependent mRNA translation shapes gene expression and cell biology 11.3
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 11.12
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 11.08
Next generation sequencing of small RNAs isolated from exosomes in human semen 11.07
Identification of HOXB13 target genes responsive to BET inhibitors 11.06
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 11.06
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 10.92
Seletive inhibition of CDK9 in DLBCL cell lines 10.87
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 10.63
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 10.49
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 10.49
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 10.49
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 10.4
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 10.4
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 10.26
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 10.26
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 10.15
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 10.07
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 9.99
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 9.92
Human embryonic stem cells in E8 and AKIT culture medium 9.92
Genome wide expression change by RNF168 knocking down in MCF-7 cells 9.84
Lipid degradation promotes prostate cancer cell survival 9.75
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 9.71
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 9.68
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 9.67
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 9.66
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 9.66
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 9.56
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 9.53
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 9.49
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 9.36
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 9.26
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 9.26
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 9.2
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 9.16
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 9.16
MOF acetyl transferase regulates transcription and respiration in mitochondria 9.16
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 9.11
Transcriptome analysis in Neobractatin treated cells 9.11
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 9.1
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 9.09
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 9.07
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 9.07
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 9.05
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.04
A prostate cancer chromatin interaction map 9.03
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 9.01
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 8.98
Effect of BMP inhibition or stimulation of primary human keratinocytes 8.98
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 8.93
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 8.93
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 8.91
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.91
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 8.79
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 8.55
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 8.53
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 8.53
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 8.46
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 8.44
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 8.29
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 8.29
Global response to chemotherapy-induced apoptosis 8.29
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 8.23
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 8.21
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 8.19
HNRNPL and its RNA Targets in Prostate Cancer 8.19
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.19
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 8.19
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 8.19
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 8.18
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.18
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 8.16
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 8.1
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 8.0
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.94
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.83
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 7.76
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 7.7
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.65
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 7.64
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 7.64
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 7.61
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.59
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 7.57
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 7.56
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 7.55
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 7.52
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 7.44
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 7.39
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.38
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.37
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 7.35
Gene Expression Profiling of SPOP Knocked Down Cell 7.34
Transcriptomes of human monocytes after ex vivo exposure to uric acid 7.33
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 7.26
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 7.26
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 7.25
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 7.25
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 7.23
Identification of the role of polydom in neurofibromas 7.21
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 7.18
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 7.18
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 7.18
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 7.18
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 7.16
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 7.12
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 7.1
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.07
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 7.06
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 7.06
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 7.06
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 7.06
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 7.03
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 7.02
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 7.02
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 6.99
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 6.97
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.97
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.97
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 6.96
Landscape of H3K4me3 in human CD19 cells 6.93
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 6.92
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 6.91
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 6.9
Gene expression changes upon drug withdrawal (Mel888 cell line) 6.87
Total RNA sequencing of APC mutant and wt colonic organoids 6.84
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 6.84
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.83
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.78
PTHrP overexpression in MCF7 cells 6.77
Ribosomal footprinting of MDA-Parental and MDA-LM2 6.77
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.75
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.74
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 6.71
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 6.68
SNHG5 siRNA knock down in HCT116 cells 6.65
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 6.64
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 6.57
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 6.57
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 6.54
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 6.53
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 6.53
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 6.52
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 6.51
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 6.5
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 6.42
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 6.42
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.42
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 6.41
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 6.4
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 6.4
RNA-seq analysis of control and Myc-induced U2OS cells 6.38
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 6.37
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 6.37
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 6.33
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 6.33
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 6.26
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 6.23
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 6.1
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.05
SLIGRL-induced gene expression changes in NHEK cells 6.04
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 6.03
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.95
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 5.94
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.86
Knockdown of ADNP in HCT116 colon cancer cells 5.84
CSL RNA-Seq on HKC and SCC cell lines 5.83
CSL 5.83
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 5.82
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 5.78
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 5.71
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 5.71
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 5.67
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.64
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.63
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 5.57
Paxillin regulates genomic networks in prostate cancer [LNCaP] 5.51
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 5.46
RNA-sequencing in immortalized human mammary epithelial cells 5.46
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.45
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 5.44
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 5.42
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 5.41
Transcriptome profiling of Normal and Cancerous Prostate Cells 5.41
CD74 role in transcription regulation 5.4
CD74 role in transcription regulation [RNA-seq] 5.4
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 5.38
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.33
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 5.32
Cajal bodies are linked to genome conformation [RNA-Seq] 5.32
Cajal bodies are linked to genome conformation 5.32
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 5.3
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 5.24
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 5.24
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 5.23
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.11
RNA-seq of RKO cells with cTAZ KO or putback 5.1
LncRNA expression profiling of ischemic stroke patients 5.07
Epigenome regulation during epidermal lineage commitment [RNA-seq] 5.04
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 5.04
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.03
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.03
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 5.02
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 5.02
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 5.02
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 5.02
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.98
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.98
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.96
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 4.94
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.9
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.9
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 4.87
Aneuploidy triggers an immune response 4.86
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.85
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.85
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.82
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.79
Epigenome regulation during epidermal lineage commitment 4.77
Total RNA-Seq data from leukemic patients with complex structural variants 4.76
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.76
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 4.75
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 4.6
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 4.48
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.48
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 4.46
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 4.46
Macrophage Ad5f35 M2 Challenge 4.46
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 4.42
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 4.42
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.4
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.4
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 4.37
RNA-seq of naive and primed ES cells (NHSM) 4.36
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 4.33
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 4.31
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 4.31
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 4.31
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 4.27
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 4.23
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 4.22
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.16
Defective structural RNA processing in relapsing-remitting multiple sclerosis 4.1
circRNA profile in hypopharyngeal cancer 4.08
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 4.03
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 4.03
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.02
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.02
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.02
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.99
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.99
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.96
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 3.93
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.91
p53 activity results in DNA replication fork processivity 3.9
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 3.87
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.86
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.86
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 3.82
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.8
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 3.74
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.74
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.71
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.71
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.7
Determining mRNA half-lives on a transcriptome-wide scale 3.63
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.61
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 3.56
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 3.56
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.55
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.52
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.47
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 3.46
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.46
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.45
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.45
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.44
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.43
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.37
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.37
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.29
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 3.28
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.26
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.25
Transcriptome analysis of peripheral blood monocytes 3.23
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 3.16
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.16
Copper Regulation of HIF-1 Transcription Activity 3.02
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.02
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.97
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.94
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.86
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.83
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 2.82
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 2.8
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 2.79
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 2.79
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.77
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.77
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 2.71
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.7
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.7
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.65
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 2.64
Transcriptome-wide modulation of splicing by the exon junction complex 2.62
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.61
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.61
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.6
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.55
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.5
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.49
Frailty in middle age is associated with race-specific changes to the transcriptome. 2.49
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 2.46
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.38
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.33
SRSF1 role in cellular gene expression and splicing 2.3
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.26
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 2.25
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.25
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.17
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 2.11
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 2.11
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 2.08
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.03
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.98
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.98
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.84
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.79
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.79
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.78
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.77
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.77
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.74
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 1.7
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.67
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.66
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.66
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.66
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.61
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.61
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.61
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.6
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.59
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.54
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 1.54
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 1.54
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.48
Aging-associated patterns in the expression of human endogenous retroviruses 1.46
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.44
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.41
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.39
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.35
ML29755 RNA-seq data 1.3
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 1.29
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.26
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.24
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.18
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.16
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.13
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.11
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.11
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.11
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.09
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.06
Activity-dependent transcriptional changes in human neurons 1.04
Noncoding regions are the main source of targetable tumor-specific antigens 0.96
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.95
Expression profiling of converted and control dermal BJ fibroblasts 0.95
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.92
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.92
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.9
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.88
N6-methyladenine DNA Modification in Glioblastoma 0.88
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.88
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.88
CD86 regulates a pro-survival signal in myeloma cells 0.76
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.75
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.71
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.7
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.69
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.66
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.66
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.64
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.63
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.59
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.57
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.57
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.54
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.53
Illumina Total RNA-seq in HeLa 0.52
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.52
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.51
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.48
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.37
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.37
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.3
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.3
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.28
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.27
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 0.26
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.26
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.25
Expression analysis of the TAF1 syndrome 0.25
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.25
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.23
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.22
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.21
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.21
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.19
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.15
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.15
HNRNPM-regulated splicing dependencies in prostate cancer 0.15
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.15
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.13
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.13
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.11
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.08
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.06
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.04
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation